DECEMBER - 20225TECH OUTLOOKCXO INSIGHTSLAST WORDC O NT E NT SIN MY OPINION08Accelerating Drug Development of Novel Targeted Therapies through Histology-Agnostic Oncology Clinical TrialsHua Gong, SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab24Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]Follow the PatientsDirk Otto,General Manager,Australia and New Zealand,Boehringer Ingelheim21Driving Digital Solutions During Challenging TimeDannarjaya Harinta Sri, VP Operations and Technology,PT Anugerah Pharmindo Lestari (APL)22Leveraging AI/ML to Transform Pharmaceutical IndustryAlexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceutical25Revamping Drug Discovery and Development through Technology InnovationDr. Michelle M. Chen, VP and Head of Corporate Development, WuXi Biologics26TOP 10 PHARMACHIEF COMPLIANCE OFFICER2022HONORED BYPHARMATECH OUTLOOKCleanroom Technology: Contamination Control of Sterile Medicinal ProductsPatrick Nieuwenhuizen, Director Senior Consultant, PharmaaLex28New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers Anders Damholt, PhD Biochemistry,Head of Clinical Development Human Health Innovation,CHR. Hansen 38PG - 32
< Page 4 | Page 6 >